ArticleJournal of translational medicine2022

Soluble CCR2 gene therapy controls joint inflammation, cartilage damage, and the progression of osteoarthritis by targeting MCP-1 in a monosodium iodoacetate (MIA)-induced OA rat model.

Hyun Sik Na et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.